Molecular Diagnostics Company Names CTO to Board
Health Discovery, a leader in support vector machine based molecular diagnostics, appointed Dr. John A. Norris, JD, MBA, 65, as CEO. Prior to his appointment, he served as the Company's EVP, CTO, and Chief Regulatory Officer for the past three years. He is a Former Principal Deputy Commissioner and COO of the US FDA (Food and Drug Administration). He is a former Director and Co-Leader of the turnaround of Summit Technology, inventor of computer-driven laser eye surgery. In addition, he is a Former Corporate Officer, Corporate EVP, and Worldwide Managing Director for Life Sciences Coaching and Consulting at Hill & Knowlton. He was CEO and is now Chairman of Needlebot, Norris Capital, and FDDH (Food, Drug, Device, and Healthcare). He is also the Founder and Former Faculty-Editor-in-Chief and CEO of the academic journal, The American Journal of Law and Medicine, which he founded at Harvard, MIT, and Boston University, and which is now housed at Boston University.
Vitesse CTO Names to Industry Board
Martin Nuss, 55, Vitesse Semiconductor’s Chief Technical Officer and VP of Technology & Strategy, has been named to the board of directors for the Alliance for Telecommunications Industry Solutions (ATIS). Nuss joined the group to focus on next-generation wired and wireless networks. He has more than 20 years of technical and management experience. He served as the CTO of Ciena's Optical Ethernet group, where he led the successful integration of the products and technology acquired from Internet Photonics. He founded Internet Photonics and served as its CTO. Mr. Nuss had been 15 years with Bell Labs in various technical and management roles including served as its Director of the Optical Data Networks Research Department.
Date Range - January 1st - January 27th